6.29
0.17 (2.70%)
| Previous Close | 6.12 |
| Open | 6.14 |
| Volume | 49,804 |
| Avg. Volume (3M) | 64,320 |
| Market Cap | 101,515,888 |
| Price / Sales | 0.360 |
| Price / Book | 0.350 |
| 52 Weeks Range | |
| Earnings Date | 29 Oct 2025 |
| Profit Margin | -59.13% |
| Operating Margin (TTM) | -40.32% |
| Diluted EPS (TTM) | -10.13 |
| Quarterly Revenue Growth (YOY) | 12.30% |
| Total Debt/Equity (MRQ) | 2.39% |
| Current Ratio (MRQ) | 2.92 |
| Operating Cash Flow (TTM) | -92.69 M |
| Levered Free Cash Flow (TTM) | -21.27 M |
| Return on Assets (TTM) | -20.31% |
| Return on Equity (TTM) | -43.21% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Health Information Services (US) | Bullish | Mixed |
| Health Information Services (Global) | Bullish | Mixed | |
| Stock | American Well Corporation | Bullish | Bearish |
AIStockmoo Score
| Analyst Consensus | 3.5 |
| Insider Activity | -3.0 |
| Price Volatility | 0.5 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | -2.5 |
| Average | 0.00 |
|
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others. |
|
| Sector | Healthcare |
| Industry | Health Information Services |
| Investment Style | Small Value |
| % Held by Insiders | 5.35% |
| % Held by Institutions | 46.84% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Alerce Investment Management, L.P. | 31 Dec 2024 | 523,785 |
| 52 Weeks Range | ||
| Median | 12.00 (90.93%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Wells Fargo | 07 Aug 2025 | 12.00 (90.93%) | Buy | 7.36 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| GOTLIB PHYLLIS | - | 6.18 | -4,959 | -30,647 |
| MCNEICE PAUL FRANCIS | - | 6.18 | -332 | -2,052 |
| Aggregate Net Quantity | -5,291 | |||
| Aggregate Net Value ($) | -32,698 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | 6.18 | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| GOTLIB PHYLLIS | Officer | 01 Oct 2025 | Sell (-) | 4,959 | 6.18 | 30,647 |
| MCNEICE PAUL FRANCIS | Officer | 01 Oct 2025 | Sell (-) | 332 | 6.18 | 2,052 |
| Date | Type | Details |
|---|---|---|
| 08 Aug 2025 | Announcement | Amwell makes grant to new employees under inducement plan |
| 05 Aug 2025 | Announcement | Amwell® Announces Results for Second Quarter 2025 |
| 05 Aug 2025 | Announcement | Amwell set to continue to enable U.S. Defense Health Agency healthcare teams to deliver connected and seamless in-person and virtual care for the Military Health System (“MHS”) |
| 22 Jul 2025 | Announcement | Amwell® to report second quarter 2025 operating results; company leaders to attend upcoming investor conferences |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |